IBER.WS

Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

IBER.WS was delisted on the 15th of February, 2023.

Back to rankings

21 hedge funds and large institutions have $3.14M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.24M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$73K
2
+$65.6K
3
+$33K
4
BCM
Basso Capital Management
Connecticut
+$32K
5
Wells Fargo
Wells Fargo
California
+$23K

Top Sellers

1
-$57K
2
-$31K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.45M
2
$230K
3
$207K
4
$130K
5
$127K
6
$122K
7
$120K
8
$120K
9
$105K
10
$90K
11
$83K
12
$73K
13
$73K
14
$60K
15
$33K
16
$32K
17
$24K
18
$22K
19
$15K
20
$11K
21
$7K
22
–
23
–